Dabigat 75 Capsule

Manufactured byNatco Pharma Ltd.
ContainsDabigatran
OFFER
Get 25% OFF!
Valid on prescription medicines, only for first time user
PRACTO
PRACTO
COPY CODE
Description

Dabigat 75 Capsule is an anticoagulant used to reduce the risk of stroke and prevent as well as treat the formation of blood clots (conditions such as deep vein thrombosis, pulmonary embolism, systemic thromboembolism, etc.) in patients suffering from atrial fibrillation as well as patients who have undergone a hip replacement surgery. This medicine is not recommended for use in patients less than 18 years of age.

Substitutes

List of substitutes for Dabigat 75 Capsule

Pradaxa 75 mg Capsule
Boehringer Ingelheim India Pvt. Ltd.

Side effects

Major & minor side effects for Dabigat 75 Capsule

  • Constipation
  • Belching
  • Nausea
  • Black or Tarry stools
  • Vomiting
  • Cough
  • Dizziness
  • Loss of consciousness
  • Fast/irregular heart beat

Uses of Dabigat 75 Capsule

What is it prescribed for?

  • Deep Vein Thrombosis and Pulmonary Embolsim
  • Prevention of Thromboembolism in Atrial Fibrillation
Read More
Concerns

Commonly asked questions

  • Onset of action
    The peak effect of this medicine can be observed within 1 to 2 hours of administration of the dose.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to dabigatran or any other inactive ingredients present along with this medicine.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
General warnings

Impaired kidney function

This medicine should be used with extreme caution in patients suffering from kidney function impairment due to the increased risk of severe adverse effects. Close monitoring of kidney function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Gastrointestinal Bleeding

This medicine is not recommended for use in patients suffering from gastrointestinal bleeding or peptic ulcer disease due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative should be considered based on the clinical condition of the patient.

Surgeries

This medicine should be used with extreme caution in patients undergoing surgeries, especially of the brain or spinal cord due to the increased risk of excessive bleeding and spinal hematomas. Close monitoring of prothrombin time, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Enoxaparin

Heparin

Itraconazole

Quinidine

Bromfenac

Disease interactions

Valvular Heart Disease

This medicine is not recommended for use in patients with a history of valvular heart diseases since the safety and efficacy of use are not clinically established for these patients. Replacement with a suitable alternative should be considered based on the clinical condition of the patient.

Active bleeding disorder

This medicine is not recommended for use in patients suffering from an active bleeding disorder due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative should be considered based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine with or without food. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
It prevents the blood from clotting by blocking the action of clotting factors.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Thrombin inhibitors

Schedule

Schedule H

[Internet]. Medicines.org.uk. 2018 [cited 24 July 2018]. Available from:

https://www.medicines.org.uk/emc/files/pil.4703.pdf?filename=PIL.4703.pdf

[Internet]. Medicines.org.uk. 2018 [cited 24 July 2018]. Available from:

https://www.medicines.org.uk/emc/files/pil.6229.pdf

[Internet]. Cec.health.nsw.gov.au. 2018 [cited 24 July 2018]. Available from:

http://www.cec.health.nsw.gov.au/__data/assets/pdf_file/0006/326418/noac_dabigatran_patient_information.pdf

Dabigatran etexilate - DrugBank [Internet]. Drugbank.ca. 2018 [cited 24 July 2018]. Available from:

https://www.drugbank.ca/drugs/DB06695

Dabigatran: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 24 July 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a610024.html
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Book a doctor

Chat with verified doctors starting @ ₹99
Book now
Something doesn’t feel right?
Report an error